Clinical Trial Update: Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study [Phase 3]

View source ↗

Summary

The PHANTOM trial, a Phase 3 pilot study comparing metformin to placebo in patients with heart failure and type 2 diabetes, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Alberta | Conditions: Diabetes Mellitus, Type 2, Heart Failure, Congestive | Phase 3 | Status: TERMINATED